Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment.

Marketa Komloova; Kamil Musilek; Anna Horova; Ondrej Holas; Vlastimil Dohnal; Frank J Gunn-Moore; Kamil Kuca

Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment.

Marketa Komloova, Kamil Musilek, Anna Horova, Ondrej Holas, Vlastimil Dohnal, Frank J Gunn-Moore, Kamil Kuca

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2505-2509
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	21
Publication status	Published - 2011

Cite this

@article{7014ebfdc4f04cf698b6366177d17db2,

title = "Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment.",

author = "Marketa Komloova and Kamil Musilek and Anna Horova and Ondrej Holas and Vlastimil Dohnal and Gunn-Moore, {Frank J} and Kamil Kuca",

year = "2011",

language = "English",

volume = "21",

pages = "2505--2509",

journal = "Bioorganic and Medicinal Chemistry Letters",

publisher = "Elsevier",

}

TY - JOUR

T1 - Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment.

AU - Komloova, Marketa

AU - Musilek, Kamil

AU - Horova, Anna

AU - Holas, Ondrej

AU - Dohnal, Vlastimil

AU - Gunn-Moore, Frank J

AU - Kuca, Kamil

PY - 2011

Y1 - 2011

M3 - Article

VL - 21

SP - 2505

EP - 2509

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

ER -